Role of CYP1B1 Retinoid in Congenital Glaucoma
Principal Investigator
Ivaylo Stoilov, MD
University of Connecticut Health Center
Farmington, CT, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$50,000
Active Dates
April 01, 2001 - March 31, 2003
Grant ID
G2001021
Summary
Some newborns and infants are affected by an especially severe form of glaucoma called Primary Congenital Glaucoma (PCG). PCG is caused by an abnormal development of the anterior chamber angle of the eye. In previous studies, Dr. Stoilov has found that this disease is caused by mutations in the gene for Cytochrome P4501B1 (CYPlBl). Humans have more than fifty different cytochrome P450 genes. They are responsible for the synthesis of various hormones and for detoxifying drugs, alcohol, and other chemicals. Based on the substrate specificity of CYPlBl, Dr. Stoilov hypothesizes that CYP1B1 affects a little-known retinoid signaling pathway operating during the later stages of eye development. Dr. Stoilov’s goal is to identify the enzymes involved in the CYPlBl pathway and study their expression during the development of the anterior chamber angle of the eye.
Related Grants
National Glaucoma Research
Maldevelopment of Schlemm's Canal in Children with Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Revathi Balasubramanian, PhD
Current Organization
Columbia University
Maldevelopment of Schlemm's Canal in Children with Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Revathi Balasubramanian, PhD
Current Organization
Columbia University
National Glaucoma Research
Using Artificial Intelligence to Discover Genetic Risk Factors for Glaucoma Worsening
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Nazlee Zebardast, MD, MPH
Current Organization
Massachusetts Eye and Ear Infirmary
Using Artificial Intelligence to Discover Genetic Risk Factors for Glaucoma Worsening
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Nazlee Zebardast, MD, MPH
Current Organization
Massachusetts Eye and Ear Infirmary
National Glaucoma Research
Understanding Optic Nerve Head Astrocyte Contributions to Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Evan Cameron, PhD
Current Organization
Cleveland Clinic - Lerner Research Institute
Understanding Optic Nerve Head Astrocyte Contributions to Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Evan Cameron, PhD
Current Organization
Cleveland Clinic - Lerner Research Institute